Screener
Protagonist Therapeutics PTGX Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Protagonist Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Protagonist Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091123
FAQ
- What is Protagonist Therapeutics's net margin?
- Protagonist Therapeutics (PTGX) reported net margin of 29.4% in Q2 2026.
- How has Protagonist Therapeutics's net margin changed year-over-year?
- Protagonist Therapeutics's net margin increased by 18.2% year-over-year, from 24.9% to 29.4%.
- What is the long-term trend for Protagonist Therapeutics's net margin?
- Over 3 years (2021 to 2025), Protagonist Therapeutics's net margin has grown at a -14.9% compound annual growth rate (CAGR), from -458.9% to -282.8%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Protagonist Therapeutics's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude